Parsabiv Injection, Solution
Product Images NDC 55513-741

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Parsabiv (NDC 55513-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Etelcalcetide Hci. (Parsabiv 01)

FDA Label Image

Principal Display Panel10 X 0.5 mL Single-dose Vialsndc 55513-740-10amgen®parsabivtm (etelcalcetide)injection2.5 mg/0.5 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 02)

Principal Display Panel10 X 0.5 mL Single-dose Vialsndc 55513-740-10amgen®parsabivtm (etelcalcetide)injection2.5 mg/0.5 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 02)
This appears to be a label or package insert for a medication called "Parsabiv" by Amgen. It is intended for intravenous use after hemodialysis, provided in single-dose vials, and should be stored in its original carton to protect it from light. The solution is sterile and preservative-free. There may be some additional information contained in the unreadable characters, but otherwise, no further description can be provided.*
FDA Label Image

Principal Display Panel10 X 1 mL Single-dose Vialsndc 55513-741-10amgen®parsabivtm (etelcalcetide)injection5 mg/mlfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 03)

Principal Display Panel10 X 1 mL Single-dose Vialsndc 55513-741-10amgen®parsabivtm (etelcalcetide)injection5 mg/mlfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 03)
SParsabiv by Amgen is a sterile, preservative-free solution for intravenous use after hemodialysis. It is available in 10 x 1 mL single-dose vials and must be stored at 2°C to 8°C in the original carton to protect it from light. Any unused portion should be discarded. The text also includes some alphanumeric codes and characters that are not comprehensible.*
FDA Label Image

Ndc 55513-742-10amgen®parsabivtm (etelcalcetide)injection10 mg/2 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 04)

Ndc 55513-742-10amgen®parsabivtm (etelcalcetide)injection10 mg/2 mLfor Intravenous Use After Hemodialysissingle-dose Vial. Discard Unused Portionstore At 2°c To 8°c (36°f To 46°f) In The Original Carton In Order To Protect From Light.sterile, Preservative-free Solutionrx Only (Parsabiv 04)
The text contains a product description for Parsabiv, a medication used for intravenous use after hemodialysis. It comes in a single-dose vial with a concentration of 10mg/2mL, and the unused portion should be discarded. The medication should be stored at 2°C to 8°C to protect it from light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.